Evidence map›Paper›PMID 22013113›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Binding of anti-SSA antibodies to apoptotic fetal cardiocytes stimulates urokinase plasminogen activator (uPA)/uPA receptor-dependent activation of TGF-β and potentiates fibrosis.

Paraskevi Briassouli, Daniel Rifkin, Robert M Clancy, Jill P Buyon

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00074373 (The Research Registry for Neonatal Lupus), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00074373 completednot on this map

The Research Registry for Neonatal Lupus

TypeobservationalSponsorNYU Langone HealthRan2010 to 2016Enrolled100ConditionsNeonatal Lupus, Systemic Lupus Erythematosus, Sjogren's Syndrome, Congenital Heart BlockArmsNo intervention, observational
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Transforming growth factor-β in tissue fibrosis.The Journal of experimental medicine · 2020
    Review
  5. Article
  6. Update on Pathogenesis of Sjogren's Syndrome.Current rheumatology reviews · 2017
    Review
  7. Article
  8. Article
  9. Autoantibodies in Sjögren's Syndrome.Rheumatic diseases clinics of North America · 2016
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. A model for lupus brain disease.Immunological reviews · 2012
    Review
  18. Clinical and pathological roles of Ro/SSA autoantibody system.Clinical & developmental immunology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paraskevi BriassouliDivision of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY 10016, USA. pbriassou@mac.com
Daniel Rifkin
Robert M Clancy
Jill P Buyon
New York University · US

Funding

Regulation of TGF-Beta Activity in the Lung by LTBP-4R01CA034282 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RIFKIN, DANIEL B · 1985 to 2016
$5.8M
Maternal Autoantibodies: Pathogenesis of Neonatal LupusR37AR042455 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2008 to 2018
$4.0M
MATERNAL AUTOANTIBODIES--PATHOGENESIS OF NEONATAL LUPUSR01AR042455 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL PAMELA · 1994 to 2007
$2.7M
uPA/uPAR and Ro60 in the pathogenesis of congenital heart blockK01AR060302 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BRIASOULI, PARASKEVI · 2011 to 2013
$347k
RESEARCH REGISTRY FOR NEONATAL LUPUS-264942220N01AR042220 · NIAMS · HOSPITAL FOR JOINT DISEASES ORTHO INST · 1994 to 2003
$148k
NCI NIH HHS CA034282NCI NIH HHS R01 CA034282NIAMS NIH HHS 1K01AR060302-01A1NIAMS NIH HHS AR-42455NIAMS NIH HHS K01 AR060302NIAMS NIH HHS N01 AR042220NIAMS NIH HHS N01-AR-4-2271NIAMS NIH HHS R01 AR042455NIAMS NIH HHS R37 AR042455
6 · The paper itself

Abstract

In congenital heart block (CHB), binding of maternal anti-SSA/Ro Abs to fetal apoptotic cardiocytes impairs their removal by healthy cardiocytes and increases urokinase plasminogen activator (uPA)/uPA receptor (uPAR)-dependent plasmin activation. Because the uPA/uPAR system plays a role in TGF-β activation, we evaluated whether anti-Ro binding to apoptotic cardiocytes enhances plasmin-mediated activation of TGF-β, thereby promoting a profibrosing phenotype. Supernatants from cocultures of healthy cardiocytes and apoptotic cardiocytes bound by IgG from a mother whose child had CHB (apoptotic-CHB-IgG [apo-CHB-IgG]) exhibited significantly increased levels of active TGF-β compared with supernatants from cocultures of healthy cardiocytes and apoptotic cardiocytes preincubated with IgG from a healthy donor. Treatment of the culture medium with anti-TGF-β Ab or TGF-β inhibitor (SB431542) abrogated the luciferase response, thereby confirming TGF-β dependency. Increased uPA levels and activity were present in supernatants generated from cocultures of healthy cardiocytes and apo-CHB-IgG cardiocytes compared with healthy cardiocytes and apoptotic cardiocytes preincubated with IgG from a healthy donor, respectively. Treatment of apo-CHB-IgG cardiocytes with anti-uPAR or anti-uPA Abs or plasmin inhibitor aprotinin prior to coculturing with healthy cardiocytes attenuated TGF-β activation. Supernatants derived from cocultures of healthy cardiocytes and apo-CHB-IgG cardiocytes promoted Smad2 phosphorylation and fibroblast transdifferentiation, as evidenced by increased smooth muscle actin and collagen expression, which decreased when fibroblasts were treated with supernatants from cocultures pretreated with uPAR Abs. These data suggested that binding of anti-Ro Abs to apoptotic cardiocytes triggers TGF-β activation, by virtue of increasing uPAR-dependent uPA activity, thus initiating and amplifying a cascade of events that promotes myofibroblast transdifferentiation and scar.

Indexed as

Binding Sites, AntibodyApoptosisAutoantibodiesCells, CulturedCell TransdifferentiationCicatrixCoculture TechniquesFemaleFetal HeartFibrosisHumansMyocytes, CardiacReceptors, Urokinase Plasminogen ActivatorRibonucleoproteinsSS-A AntigenTransforming Growth Factor betaAutoantibodiesReceptors, Urokinase Plasminogen ActivatorRibonucleoproteinsSS-A AntigenTransforming Growth Factor betaUrokinase-Type Plasminogen Activator

Identifiers

PMID22013113
PMCPMC3208032
OpenAlexW2144319600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.